BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
-6.36%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.58B
AUM Growth
+$1.58B
Cap. Flow
-$12.5M
Cap. Flow %
-0.79%
Top 10 Hldgs %
42.1%
Holding
79
New
5
Increased
1
Reduced
2
Closed
3

Top Buys

1
SRPT icon
Sarepta Therapeutics
SRPT
$15M
2
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
$12.8M
3
ASND icon
Ascendis Pharma
ASND
$6.51M
4
ETNB icon
89bio
ETNB
$4.51M
5
COGT icon
Cogent Biosciences
COGT
$3.83M

Top Sells

1
ITOS icon
iTeos Therapeutics
ITOS
$21.4M
2
XBI icon
SPDR S&P Biotech ETF
XBI
$14.9M
3
RARE icon
Ultragenyx Pharmaceutical
RARE
$14.5M
4
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
$5.55M
5
GNCA
Genocea Biosciences, Inc.
GNCA
$1.42M

Sector Composition

1 Healthcare 96.9%
2 Financials 0.75%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$134M 8.5% 2,000,000 – –
CYTK icon
2
Cytokinetics
CYTK
$4.23B
$82.5M 5.23% 2,100,000 – –
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$80.9M 5.13% 500,000 – –
RVMD icon
4
Revolution Medicines
RVMD
$7.1B
$67.9M 4.3% 3,484,264 – –
APLS icon
5
Apellis Pharmaceuticals
APLS
$3.48B
$59M 3.73% 1,303,700 – –
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
$51.1M 3.24% 2,075,905 – –
PMVP icon
7
PMV Pharmaceuticals
PMVP
$74.2M
$49.9M 3.16% 3,498,636 – –
RXDX
8
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$48.4M 3.06% 1,714,000 – –
TYRA icon
9
Tyra Biosciences
TYRA
$675M
$46.1M 2.92% 6,448,359 – –
RLAY icon
10
Relay Therapeutics
RLAY
$619M
$44.7M 2.83% 2,669,132 – –
ITOS icon
11
iTeos Therapeutics
ITOS
$449M
$44.4M 2.81% 2,154,058 -1,038,000 -33% -$21.4M
MRUS icon
12
Merus
MRUS
$4.98B
$43M 2.72% 1,900,000 – –
TPTX
13
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$42.9M 2.72% 570,745 +170,745 +43% +$12.8M
AMLX icon
14
Amylyx Pharmaceuticals
AMLX
$836M
$42.4M 2.68% 2,200,000 – –
RETA
15
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$37.7M 2.38% 1,239,000 – –
XBI icon
16
SPDR S&P Biotech ETF
XBI
$5.07B
$37.1M 2.35% 500,000 -200,000 -29% -$14.9M
RCUS icon
17
Arcus Biosciences
RCUS
$1.13B
$36.3M 2.3% 1,432,200 – –
SAGE
18
DELISTED
Sage Therapeutics
SAGE
$35.3M 2.24% 1,094,000 – –
TNGX icon
19
Tango Therapeutics
TNGX
$747M
$31.1M 1.97% 6,871,642 – –
IDYA icon
20
IDEAYA Biosciences
IDYA
$2.15B
$30.4M 1.93% 2,202,812 – –
BLU
21
DELISTED
BELLUS Health Inc.
BLU
$29.6M 1.87% 3,200,000 – –
ANAB icon
22
AnaptysBio
ANAB
$569M
$26.4M 1.67% 1,300,000 – –
BPMC
23
DELISTED
Blueprint Medicines
BPMC
$25.6M 1.62% 507,374 – –
FOLD icon
24
Amicus Therapeutics
FOLD
$2.34B
$25M 1.58% 2,325,000 – –
KNTE
25
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$23.3M 1.48% 1,847,559 – –
1
2 3 4